Taher Al-Tweigeri
Overview
Explore the profile of Taher Al-Tweigeri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkum N, Aboussekhra A, Aboussekhra M, Aldalham H, Alshehri L, Alessy S, et al.
J Epidemiol Glob Health
. 2025 Mar;
15(1):36.
PMID: 40063309
Background: Understanding the ethnic molecular subtype characteristics of breast cancer (BC) in Saudi women is crucial for providing comprehensive prognostic information and optimizing patient outcomes, making it essential to study...
2.
Qattan A, Al-Tweigeri T, Suleman K, Alkhayal W, Tulbah A
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272915
Triple-negative breast cancer is aggressive and challenging to treat because of a lack of targets and heterogeneity among tumors. A paramount factor in the mortality from breast cancer is metastasis,...
3.
Alshamsan B, Elshenawy M, Aseafan M, Fahmy N, Badran A, Elhassan T, et al.
Oncol Lett
. 2024 Jul;
28(3):429.
PMID: 39049989
The present study aimed to clarify the prognostic role of the pre-treatment neutrophil-to-lymphocyte ratio (NLR) for the response to neoadjuvant chemotherapy (NAC) in locally advanced breast cancer (LABC). Due to...
4.
Islam S, Al-Tweigeri T, Al-Harbi L, Ujjahan S, Al-Mozaini M, Tulbah A, et al.
Cell Death Discov
. 2024 Jan;
10(1):61.
PMID: 38296962
Breast cancer (BC) patient who receives chemotherapy for an extended length of time may experience profound repercussions in terms of metastases and clinical outcomes due to the involvement of the...
5.
Al-Tweigeri T
Hematol Oncol Stem Cell Ther
. 2023 Aug;
17(1):1-3.
PMID: 37581461
No abstract available.
6.
Al-Tweigeri T, Alraouji N, Tulbah A, Arafah M, Aboussekhra M, Al-Mohanna F, et al.
Breast Cancer Res
. 2022 Jul;
24(1):46.
PMID: 35821051
Background: Locally advanced breast cancer (LABC), the most aggressive form of the disease, is a serious threat for women's health worldwide. The AU-rich RNA-binding factor 1 (AUF1) promotes the formation...
7.
Al-Kharashi L, Tulbah A, Arafah M, Eldali A, Al-Tweigeri T, Aboussekhra A
Front Oncol
. 2022 Jun;
12:877219.
PMID: 35719957
Background: Active breast cancer-associated fibroblasts (CAFs) play a leading role in breast carcinogenesis through promoting angiogenesis and resistance to therapy. Consequently, these active stromal cells have significant influence on patient...
8.
Alshamsan B, Suleman K, Agha N, Abdelgawad M, Alzahrani M, Elhassan T, et al.
Int J Womens Health
. 2022 Mar;
14:373-384.
PMID: 35309953
Purpose: Obesity is prevalent in Saudi Arabia and is associated with adverse clinical features and poor breast cancer (BC) outcomes. We determined the distribution of body mass index (BMI) and...
9.
Qattan A, Al-Tweigeri T, Suleman K
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203574
Triple-negative breast cancers (HER2-, ER-, PR-) continue to present a unique treatment challenge and carry unfavorable prognoses. The elucidation of novel therapeutic targets has necessitated the re-evaluation of stratification approaches...
10.
Alshamsan B, Alshibany A, Elshenawy M, Badran A, Elhassan T, Ajarim D, et al.
Cancer Manag Res
. 2022 Jan;
13:9411-9420.
PMID: 35002318
Purpose: The correlation between the preoperative neutrophil-to-lymphocyte ratio (NLR) and Oncotype DX (ODX) recurrence score (RS) has not yet been established. We aimed to investigate the association between NLR and...